Observational study finds GLP 1 medications associated with reduced emergency visits and lower drug needs for chronic migraine
A preliminary study shows GLP 1 medications are associated with fewer emergency room visits and a lower need for supplemental drugs in chronic migraine patients.
By: AXL Media
Published: Mar 2, 2026, 6:07 AM EST
Source: The information in this article was sourced from American Academy of Neurology

HEADLINE
Observational study finds GLP 1 medications associated with reduced emergency visits and lower drug needs for chronic migraine
SUMMARY
Patients using GLP 1 receptor agonists for diabetes or weight loss show a decreased reliance on emergency medical care and supplemental medications for chronic migraine compared to those on standard preventive therapy. Data to be presented at the American Academy of Neurology indicates that these patients were significantly less likely to require hospitalizations or new prescriptions for common migraine treatments.
CONTENT
Comparative analysis of migraine disease burden
Categories
Topics
Related Coverage
- Cleveland Clinic Study Finds 45% of Patients Maintain Weight Loss One Year After Halting GLP-1 Medications
- Experimental Five-Target Molecule Outperforms Semaglutide in Correcting Obesity and Diabetes in Preclinical Trials
- New Genetic Study Identifies Why GLP-1 Weight Loss Efficacy and Side Effects Vary Between Patients
- FDA Grants Approval for High-Dose Wegovy as Novo Nordisk Battles Eli Lilly for Weight-Loss Dominance